A Different Angle - RemeGen Vs Akeso (Insights on Valuation)
In this article, by comparing RemeGen and Akeso's pipelines from different aspects to provide referable and helpful insights about the valuation...
531 Views
Bio-Thera Solutions (百奥泰) A+H: Not an Attractive Pipeline
Bio-Thera is a China-based biopharmaceutical company. The company plans to raise at least USD 500m to list in Hong Kong.
396 Views
Pre-IPO RemeGen - Insights on Two Core Products RC18 & RC48
This article analyzed two core products from RemeGen: RC18 and RC 48. The commercialization of these two products would have direct impact on the...
613 Views